Search

This annual symposium will convene both U.S. and global leaders to map a unified strategy for global pandemic preparedness. We will discuss how leading health organizations can come together to prepare for future outbreaks and what to do in the early stages of an outbreak to produce a coordinated...

Two mRNA-1273 vaccine doses reduced the incidence of COVID-19 infection in younger adults, though factors beyond vaccination may have contributed to infection risk.

This year's theme for Women's History Month is "Providing Healing, Promoting Hope." For Kathryn E. Stephenson, MD, MPH of Beth Israel Deaconess Medical Center's Center for Virology and Vaccine Research, it calls to mind the progress that has taken place since the beginning of the COVID-19 pandemic....

Key takeaways: Eighty-three percent of patients maintained virologic suppression after the bNAb cocktail for 28 weeks. Forty-two percent had virologic suppression for 38 to 44 weeks despite the decline of bNAb concentrations.

Phase 1 study is among first to examine mRNA technology for HIV.

Harvard Medical Grand Rounds Pandemic Preparedness Kathryn E. Stephenson, MD, MPH Associate Professor of Medicine, Harvard Medical School Center for Virology and Vaccine Research Beth Israel Deaconess Medical Center Infectious Disease Surveillance Jacob Lemieux, MD, PhD Assistant Professor of...